Katsumi Nakatomi Selected Research

Katsumi Nakatomi Research Topics

Disease

19	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 03/2003
12	Neoplasms (Cancer) 01/2023 - 02/2002
10	Lung Neoplasms (Lung Cancer) 11/2023 - 08/2003
9	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2023 - 03/2003
5	Adenocarcinoma of Lung 01/2017 - 11/2007
4	Adenocarcinoma 01/2017 - 05/2006
4	Breast Neoplasms (Breast Cancer) 03/2008 - 08/2003
3	Neutropenia 11/2019 - 01/2011
2	Pneumonia (Pneumonitis) 11/2023 - 04/2020
2	Disease Progression 10/2023 - 12/2011
2	Febrile Neutropenia 09/2021 - 09/2012
2	Leukopenia 11/2019 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 03/2003 - 02/2002
1	Testicular Neoplasms (Testicular Cancer) 01/2023
1	Bronchiectasis 04/2020
1	Pleural Effusion (Pleural Effusions) 01/2020
1	Pleurisy (Pleuritis) 01/2020
1	Malignant Pleural Effusion 01/2020
1	Fever (Fevers) 02/2016
1	Drug Fever 02/2016
1	Drug-Related Side Effects and Adverse Reactions 02/2016
1	Hypotension (Low Blood Pressure) 09/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2014
1	Meningeal Carcinomatosis 12/2011
1	Chemical and Drug Induced Liver Injury 12/2011
1	Neoplasm Metastasis (Metastasis) 05/2006

Drug/Important Bio-Agent (IBA)

9	ErbB Receptors (EGF Receptor)IBA 01/2023 - 02/2005
7	amrubicinIBA 01/2022 - 06/2009
6	Irinotecan (Camptosar)FDA LinkGeneric 10/2023 - 08/2003
6	Gefitinib (Iressa)FDA Link 01/2023 - 02/2005
5	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 06/2009
4	Pemetrexed (MTA)FDA Link 01/2021 - 08/2013
4	Messenger RNA (mRNA)IBA 01/2019 - 02/2002
4	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 06/2009
4	Tyrosine Kinase InhibitorsIBA 09/2013 - 02/2005
4	Proteins (Proteins, Gene)FDA Link 03/2008 - 08/2003
3	PlatinumIBA 10/2023 - 09/2012
3	Anaplastic Lymphoma KinaseIBA 01/2017 - 08/2013
3	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2005 - 08/2003
2	Etoposide (VP 16)FDA LinkGeneric 10/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2006
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2021 - 02/2016
2	Docetaxel (Taxotere)FDA Link 01/2020 - 02/2016
2	nedaplatinIBA 01/2019 - 01/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2016 - 01/2004
2	Gemcitabine FDA Link 02/2016 - 01/2011
2	Topoisomerase I InhibitorsIBA 02/2005 - 08/2003
2	Complementary DNA (cDNA)IBA 02/2005 - 01/2004
2	Adenosine Triphosphate (ATP)IBA 01/2004 - 08/2003
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2004 - 08/2003
2	Histone Deacetylases (Histone Deacetylase)IBA 03/2003 - 02/2002
2	Histone Deacetylase InhibitorsIBA 03/2003 - 02/2002
2	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2003 - 02/2002
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023
1	SteroidsIBA 11/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2023
1	B7-H1 AntigenIBA 10/2023
1	dacomitinibIBA 01/2023
1	AntigensIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	osimertinibIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2020
1	RamucirumabIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	7-ethyl-10-hydroxycamptothecin beta-glucuronideIBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	CytokinesIBA 01/2018
1	Interleukin-18 (Interleukin 18)IBA 01/2018
1	alectinibIBA 01/2017
1	CrizotinibIBA 06/2014
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 06/2014
1	CarcinogensIBA 09/2013
1	Vinorelbine (Navelbine)FDA LinkGeneric 09/2012
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2011
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 02/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2011
1	coumermycinIBA 01/2004
1	CamptothecinIBA 01/2004
1	Novobiocin (Streptonivicin)FDA Link 01/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2003
1	Coloring Agents (Dyes)IBA 08/2003
1	romidepsin (FK228)FDA Link 03/2003
1	trichostatin A (A 300)IBA 03/2003
1	Butyric Acid (Butanoic Acid)IBA 03/2003

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 09/2021 - 03/2003
4	Therapeutics 01/2023 - 01/2018
4	Radiotherapy 01/2022 - 02/2016
2	Immunotherapy 10/2023 - 01/2018
2	Combination Drug Therapy (Combination Chemotherapy) 01/2014 - 09/2012
1	Traction 04/2020
1	Chemoradiotherapy 11/2017
1	Drug Tapering 01/2017